Trials / Unknown
UnknownNCT04971434
Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping
Non-alcoholic Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping-with-scarification
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 35 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Every-two-week applied cupping (with scarification) session within one month on back of upper thorax is not compared previously regarding its effect on cardio-metabolic risk factors to the daily application of laser on acupoints (for month, except Fridays) in fatty liver patients. This trial will compare the two procedure effects on cardio-metabolic risk factors in fatty liver.
Detailed description
In fatty liver patients,every-two-week applied cupping (with scarification) session within one month on back of upper thorax for 30 patients will be compared regarding its effect on cardio-metabolic risk factors to the daily application of laser on acupoints (for month, except Fridays) of other 30 patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | laser stimulation for acupoints | In fatty liver patients (30 patients), a daily application of 4-minute laser (for one month, except Fridays) on acupoint number 25,40,36 of stomach meridian, acupoint number 3 of liver meridian, acupoint number 6 of spleen meridian,acupoint number 9,12,4 of conception vessel meridian, acupoint number 14 of governor vessel meridian, acupoint number 4, 11 of large intestine meridian, acupoint number 34 of gall bladder meridian |
| OTHER | cupping with scarification | In fatty liver patients (30 patients),every-two-week applied cupping (with scarification) session within one month on back of upper thorax |
Timeline
- Start date
- 2021-07-11
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2021-07-21
- Last updated
- 2021-07-21
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04971434. Inclusion in this directory is not an endorsement.